Detection and Management of Amyloid-Related Imaging Abnormalities in Patients with Alzheimer’s Disease Treated with Anti-Amyloid Beta Therapy

Autor: Barakos, J, Purcell, D, Suhy, J, Chalkias, S, Burkett, P, Marsica Grassi, C, Castrillo-Viguera, C, Rubino, I, Vijverberg, E

Publikováno v: Barakos, J, Purcell, D, Suhy, J, Chalkias, S, Burkett, P, Marsica Grassi, C, Castrillo-Viguera, C, Rubino, I & Vijverberg, E 2022, ' Detection and Management of Amyloid-Related Imaging Abnormalities in Patients with Alzheimer’s Disease Treated with Anti-Amyloid Beta Therapy ', Journal of Prevention of Alzheimer's Disease, vol. 9, no. 2, pp. 211-220 . https://doi.org/10.14283/jpad.2022.21

Amyloid-related imaging abnormalities (ARIA) are adverse events reported in Alzheimer’s disease trials of anti-amyloid beta (Aβ) therapies. This review summarizes the existing literature on ARIA, including bapineuzumab, gantenerumab, donanemab, le

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cd374ca6e89cfbea4135a7277241a8b
http://www.scopus.com/inward/record.url?scp=85124318139&partnerID=8YFLogxK